Golden Green’s Novavax NVAX Stock Holding History

Golden Green’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,058	Closed	-$1.46M	–	150
2021 Q3	$1.46M	Buy	+7,058	New	+$1.56M	1.14%	18
2021 Q2	–	Sell	-3,153	Closed	-$572K	–	174
2021 Q1	$572K	Sell	3,153 -1,152	-27%	-$230K	0.49%	57
2020 Q4	$480K	Buy	+4,305	New	+$458K	0.45%	65

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Golden Green's NVAX Position: Q4 2021 in Review

Golden Green sold out of Novavax (NVAX) in Q4 2021, closing a stake of 7,058 shares — an estimated $1.46M sold.

Golden Green first reported a position in NVAX in Q4 2020 and held it in 3 quarters. The position peaked at $1.46M in Q3 2021. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

Golden Green reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
Golden Green sold 7,058 Novavax shares in Q4 2021, an estimated $1.46M.
Golden Green first reported a position in Novavax in Q4 2020 and held it in 3 quarters.
Golden Green's Novavax position peaked at $1.46M in Q3 2021.
429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Golden Green's 13F filing for Q4 2021, filed 21 Jan 2022.